Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Alterity Therapeutics Ltd ADR (ATHE)

Alterity Therapeutics Ltd ADR (ATHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,933
  • Shares Outstanding, K 22,604
  • Annual Sales, $ 3,370 K
  • Annual Income, $ -11,440 K
  • 60-Month Beta 1.67
  • Price/Sales 8.73
  • Price/Cash Flow N/A
  • Price/Book 1.37
Trade ATHE with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2400 +3.23%
on 09/22/21
1.4000 -8.57%
on 09/03/21
-0.0600 (-4.48%)
since 08/24/21
3-Month
1.2400 +3.23%
on 09/22/21
2.7500 -53.45%
on 07/01/21
-0.0900 (-6.57%)
since 06/24/21
52-Week
1.0900 +17.43%
on 11/13/20
3.5800 -64.25%
on 11/16/20
-0.6099 (-32.27%)
since 09/24/20

Most Recent Stories

More News
Alterity Announces Presentation of Biomarker Data at the International Parkinson and Movement Disorder Society Congress 2021

and , /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today...

ATHE : 1.2800 (-1.54%)
Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's

/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today...

ATHE : 1.2800 (-1.54%)
Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is Neuroprotective and Improves Motor Function

/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today...

ATHE : 1.2800 (-1.54%)
Thinking about buying stock in Trxade Health, Alterity Therapeutics, ContextLogic, Acasti Pharma, or Smith & Wesson?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MEDS, ATHE, WISH, ACST, and SWBI.

ACST : 2.26 (+7.62%)
ATHE : 1.2800 (-1.54%)
MEDS : 5.08 (-1.93%)
SWBI : 21.60 (+0.42%)
WISH : 6.02 (-1.87%)
Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's

/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the United States Patent and Trademark...

ATHE : 1.2800 (-1.54%)
Thinking about buying stock in Alterity Therapeutics, GameStop, United Airlines, FuelCell Energy, or Nio?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATHE, GME, UAL, FCEL, and NIO.

ATHE : 1.2800 (-1.54%)
FCEL : 6.97 (-3.73%)
UAL : 48.79 (+2.78%)
GME : 185.16 (-3.18%)
NIO : 35.38 (-1.75%)
ATH434 protects brain cells and improves motor function in Parkinsonian disorder

, /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced an oral presentation of expanded animal data to support the commercialisation of its lead...

ATHE : 1.2800 (-1.54%)
Alterity to present at the 7th International Congress of Multiple System Atrophy

and , /PRNewswire/ -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), will present at the upcoming 7th International Congress of Multiple System Atrophy (MSA2021),...

ATHE : 1.2800 (-1.54%)
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials

, /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the award of a grant from The Michael J. Fox Foundation for Parkinson's Research to determine...

ATHE : 1.2800 (-1.54%)
Dr David Stamler Appointed CEO

, /PRNewswire/ -- The Board of Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce the appointment of Dr to the role of Chief Executive Office effective...

ATHE : 1.2800 (-1.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses....

See More

Key Turning Points

3rd Resistance Point 1.3300
2nd Resistance Point 1.3200
1st Resistance Point 1.3000
Last Price 1.2800
1st Support Level 1.2700
2nd Support Level 1.2600
3rd Support Level 1.2400

See More

52-Week High 3.5800
Fibonacci 61.8% 2.6288
Fibonacci 50% 2.3350
Fibonacci 38.2% 2.0412
Last Price 1.2800
52-Week Low 1.0900

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar